Tourette Syndrome and comorbid ADHD: Current pharmacological treatment options

European Journal of Paediatric Neurology

Volumn 17, Issue 5, 2013, Pages 421-428

  Rizzo, Renata ^a   Gulisano, Mariangela ^a   Calì, Paola V ^a   Curatolo, Paolo ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Agonist; ADHD; Comorbidity; Pharmacological treatment; Psychostimulants; Selective norepinephrine reuptake inhibitor; Tourette Syndrome

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE; ARIPIPRAZOLE; ATOMOXETINE; CENTRAL STIMULANT AGENT; CLONIDINE; DESIPRAMINE; DEXAMPHETAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; GUANFACINE; HALOPERIDOL; METHYLPHENIDATE; NEUROLEPTIC AGENT; NORADRENALIN UPTAKE INHIBITOR; PLACEBO; PSYCHOSTIMULANT AGENT;

ANOREXIA; APPETITE DISORDER; ATTENTION DEFICIT DISORDER; BLOOD PRESSURE; BODY WEIGHT; CARDIOTOXICITY; COGNITIVE THERAPY; COMORBIDITY; DECREASED APPETITE; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DOUBLE BLIND PROCEDURE; ENANTIOMER; FAINTNESS; FATIGUE; GILLES DE LA TOURETTE SYNDROME; HEADACHE; HEART RATE; HUMAN; HYPERACTIVITY; INSOMNIA; IRRITABILITY; MEDLINE; MULTIPLE CYCLE TREATMENT; NAUSEA; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; PUBLICATION; PULSE RATE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK; SEDATION; SIDE EFFECT; SLEEP DISORDER; TIC; VOMITING; WEIGHT REDUCTION;

ADHD; COMORBIDITY; PHARMACOLOGICAL TREATMENT; PSYCHOSTIMULANTS; SELECTIVE NOREPINEPHRINE REUPTAKE INHIBITOR; TOURETTE SYNDROME; Α-AGONIST;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD, PRESCHOOL; HUMANS; TIC DISORDERS; TOURETTE SYNDROME; TREATMENT OUTCOME;

EID: 84881317130     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2013.01.005     Document Type: Review

References (53)

1. M.M. Robertson, V. Eapen, and A.E. Cavanna The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: a cross cultural perspective J Psychosom Res 67 2009 475 483
2. R.D. Freeman, D.K. Fast, and L. Burd An international perspective on Tourette syndrome: selected findings from 3,500 individuals in 22 countries Dev Med Child Neurol 42 2000 436 447 (Pubitemid 30427051)
3. R.D. Freeman, and Tourette Syndrome International Database Consortium Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome Eur Child Adolesc Psychiatry 16 2007 15 23
4. J. Swanson, M. Lerner, J. March, and F.M. Gresham Assessment and intervention for attention-deficit/hyperactivity disorder in the schools. Lessons from the MTA study Pediatr Clin North Am 46 1999 993 1009 (Pubitemid 29477886)
5. H.C. Steinhausen, T.S. Nøvik, and G. Baldursson Co-existing psychiatric problems in ADHD in the ADORE cohort Eur Child Adolesc Psychiatry 1 2006 I25 I29
6. V. Roessner, A. Becker, T. Banaschewski, and A. Rothenberger Executive functions in children with chronic tic disorders with/without ADHD - new insights Eur Child Adolesc Psychiatry 16 Suppl. 1 2007 I/36 I/44
7. C.M. Eddy, A.E. Cavanna, and M. Gulisano Clinical correlates of quality of life in Tourette syndrome Mov Disord 26 2011 735 738
8. R. Rizzo, P. Curatolo, and M. Gulisano Disentangling the effects of Tourette syndrome and attention deficit hyperactivity disorder on cognitive and behavioral phenotypes Brain Dev 29 2007 413 420 (Pubitemid 46755534)
9. T. Banaschewski, B.M. Neale, A. Rothenberger, and V. Roessner Comorbidity of tic disorders & ADHD: conceptual and methodological considerations Eur Child Adolesc Psychiatry 16 Suppl. 1 2007 5 14
10. C.A. Mathews, and M.A. Grados Familiality of Tourette syndrome, obsessive-compulsive disorder, and attention-deficit/hyperactivity disorder: heritability analysis in a large sib-pair sample J Am Acad Child Adolesc Psychiatry 50 2011 46 54
11. D.L. Pauls, J.F. Leckman, and D.J. Cohen Familial relationship between Gilles de la Tourette's syndrome, attention deficit disorder, learning disabilities, speech disorders, and stuttering J Am Acad Child Adolesc Psychiatry 32 1993 1044 1050 (Pubitemid 23261086)
12. J.F. Abelson, K.Y. Kwan, and B.J. O'Roak Sequence variants in SLITRK1 are associated with Tourette's syndrome Science 310 2005 317 320 (Pubitemid 41457198)
13. J. Gunther, Y. Tian, and B. Stamova Catecholamine-related gene expression in blood correlates with tic severity in Tourette syndrome Psychiatry Res 30 2012 593 601
14. S. Cortese The neurobiology and genetics of Attention-Deficit/ Hyperactivity Disorder (ADHD): what every clinician should know Eur J Paediatr Neurol 16 2012 422 433
15. P. Curatolo, C. Paloscia, E. D'Agati, R. Moavero, and A. Pasini The neurobiology of attention deficit/hyperactivity disorder Eur J Paediatr Neurol 13 2009 299 304
16. M.B. Denckla Attention-deficit hyperactivity disorder (ADHD) comorbidity: a case for pure Tourette syndrome? J Child Neurol 21 2006 701 703 (Pubitemid 44295129)
17. Y. Kano, M. Ohta, Y. Nagai, and L. Scahill Association between Tourette syndrome and comorbidities in Japan Brain Dev 32 2010 201 207
18. L.S. Hamilton, J.G. Levitt, and J. O'Neill Reduced white matter integrity in attention deficit hyperactivity disorder Neuroreport 19 2008 1705 1708
19. D.F. Wong, J.R. Brasić, and H.S. Singer Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET Neuropsychopharmacol 33 2008 1239 1251 (Pubitemid 351521728)
20. D.A. Gorman, N. Thompson, and K.J. Plessen Psychosocial outcome and psychiatric comorbidity in older adolescents with Tourette syndrome: controlled study Br J Psychiatry 197 2010 36 44
21. S.S. Bhardwaj, F. Camacho, A. Derrow, A.B. Fleischer Jr., and S.R. Feldman Statistical significance and clinical relevance the importance of power in clinical trials in dermatology Arch Dermatol 140 2004 1520 1523 (Pubitemid 39627447)
22. M.M. Robertson The Gilles de La tourette syndrome: the current status Arch Dis Child Educ Pract Ed 97 5 2012 Oct 166 175
23. V. Roessner, K.J. Plessen, and A. Rothenberger European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment Eur Child Adolesc Psychiatry 20 2011 173 196
24. M.M. Robertson The prevalence and epidemiology of Gilles de la Tourette syndrome. Part 2: tentative explanations for differing prevalence figures in GTS, including the possible effects of psychopathology, aetiology, cultural differences, and differing phenotypes J Psychosom Res 65 2008 473 486
25. H. Weisman, I.A. Qureshi, J.F. Leckman, L. Scahill, and M.H. Bloch Systematicreview: pharmacological treatment of ticdisorders - efficacy of antipsychotic and alpha-2adrenergicagonistagents Neurosci Biobehav Rev 12 2012; 23 Oct 00161 00163 S0149-7634
26. M.M. Robertson Tourette syndrome, associated conditions and the complexities of treatment Brain 123 2000 425 462 (Pubitemid 30099531)
27. J.F. Leckman, M.T. Hardin, and M.A. Riddle Clonidine treatment of Gilles de la Tourette's syndrome Arch Gen Psychiatry 48 1991 324 328
28. Tourette's Syndrome Study Group Treatment of ADHD in children with tics: a randomized controlled trial Neurology 58 2002 527 536
29. H.S. Singer, J. Brown, and S. Quaskey The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine Pediatrics 95 1995 74 81
30. D.J. Heal, S.L. Smith, and R.L. Findling ADHD: current and future therapeutics Curr Top Behav Neurosci 9 2012 361 390
31. L. Scahill, P.B. Chappell, and Y.S. Kim A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder Am J Psychiatry 158 2001 1067 1074 (Pubitemid 32623110)
32. M.H. Bloch, K.E. Panza, A. Landeros-Weisenberger, and J.F. Leckman Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders J Am Acad Child Adolesc Psychiatry 48 2009 884 893
33. V. Roessner, M. Robatzek, G. Knapp, T. Banaschewski, and A. Rothenberger First-onset tics in patients with attention-deficit-hyperactivity disorder: impact of stimulants Dev Med Child Neurol 48 2006 616 621
34. F.X. Castellanos, J.N. Giedd, and J. Elia Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose J Am Acad Child Adolesc Psychiatry 36 1997 589 596 (Pubitemid 27184065)
35. K.D. Gadow, J. Sverd, E.E. Nolan, J. Sprafkin, and J. Schneider Immediate-release methylphenidate for ADHD in children with comorbid chronic multiple tic disorder J Am Acad Child Adolesc Psychiatry 46 2007 840 848 (Pubitemid 46975920)
36. K.D. Gadow, J. Sverd, J. Sprafkin, E.E. Nolan, and S.N. Ezor Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder Arch Gen Psychiatry 52 1995 444 455
37. K.D. Gadow, J. Sverd, J. Sprafkin, E.E. Nolan, and S. Grossman Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder Arch Gen Psychiatry 56 1999 330 336 (Pubitemid 29165176)
38. T. Günther, B. Kahraman-Lanzerath, E.L. Knospe, B. Herpertz-Dahlmann, and K. Konrad Modulation of attention-deficit/hyperactivity disorder symptoms by short- and long-actingmethylphenidate over the course of a day J Child Adolesc Psychopharmacol 22 2012 131 138
39. G.J. Lyon, S.M. Samar, and C. Conelea Testing tic suppression: comparing the effects of dexmethylphenidate to No medication in children and adolescents with attention-deficit/hyperactivity disorder and Tourette's disorder J Child Adolesc Psychopharmacol 20 2010 283 289
40. A.R. Perwien, C.J. Kratochvil, and D.E. Faries Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder: what are the long-term health-related quality-of-lifeoutcomes? J Child Adolesc Psychopharmacol 16 2006 713 724 (Pubitemid 46175427)
41. C.J. Swanson, K.W. Perry, and S. Koch-Krueger Effect of the attention deficit/hyperactivity disorder drug atomoxetine onextracellular concentrations of norepinephrine and dopamine in several brainregions of the rat Neuropharmacology 50 2006 755 760
42. A.J. Allen, R.M. Kurlan, and D.L. Gilbert Atomoxetine treatment in children and adolescents with ADHD and comorbidtic disorders Neurology 65 2005 1941 1949 (Pubitemid 43970115)
43. T.J. Spencer, F.R. Sallee, and D.L. Gilbert Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome J Atten Disord 11 2008 470 481
44. G. Masi, A. Gagliano, and R. Siracusano Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study JChild Adolesc Psychopharmacol 22 2012 120 125
45. T. Pringsheim, and T. Steeves Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders Cochrane Database Syst Rev 13 4 2011 CD007990
46. J. Graham, T. Banaschewski, and J. Buitelaar European guidelines on managing adverse effects of medication for ADHD Eur Child Adolesc Psychiatry 20 2011 17 37
47. M. Gulisano, P.V. Cali, and A.E. Cavanna Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome Neurol Sci 32 2011 1213 1217
48. J.C. Du, T.F. Chiu, and K.M. Lee Tourette syndrome in children: an updated review Pediatr Neonatol 51 2010 255 264
49. G. Erenberg The relationship between Tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review Semin Pediatr Neurol 12 2005 217 221 (Pubitemid 43850348)
50. R. Rizzo, M. Gulisano, P.V. Calì, and P. Curatolo ADHD and epilepsy in children with Tourette syndrome: a triple comorbidity? Acta Paediatr 99 2010 1894 1896
51. A. Lerner, A. Bagic, and J.M. Simmons Widespread abnormality of the γ-aminobutyric acid-ergic system in Tourette syndrome Brain 135 2012 1926 1936
52. I. Neuner, Y. Kupriyanova, and T. Stöcker White-matter abnormalities in Tourettesyndromeextendbeyondmotorpathways Neuroimage 51 2010 1184 1193
53. M.M. Robertson Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary EurChild Adolesc Psychiatry 15 2006 1 11 (Pubitemid 43333713)